| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
EP300 |
IPI00478752 |
10.830 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CDK4 |
CDK4: Cell division protein kinase 4 |
10.830 |
Evidence |
O
|
| EFNA5 |
EFNA5, EPLG7, LERK7: Ephrin-A5 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
10.750 |
Evidence |
|
| HDAC2 |
HDAC2: Histone deacetylase 2 |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
10.560 |
Evidence |
O
|
| EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
EXOSC4 |
EXOSC4, RRP41, SKI6: Exosome complex exonuclease RRP41 |
10.550 |
Evidence |
O
|
| ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
10.480 |
Evidence |
|
| SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
10.370 |
Evidence |
O
|
| VDR |
VDR, NR1I1: Vitamin D3 receptor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
10.300 |
Evidence |
O
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
10.300 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
10.180 |
Evidence |
O
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
10.020 |
Evidence |
O
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
BIRC3 |
BIRC3, API2, IAP1, MIHC, RNF49: Baculoviral IAP repeat-containing protein 3 |
9.952 |
Evidence |
O
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
9.925 |
Evidence |
|
| EFNA4 |
EFNA4, EPLG4, LERK4: Ephrin-A4 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
9.472 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
8.962 |
Evidence |
O
|
| CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
8.927 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
8.892 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
8.745 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
PMS2 |
PMS2: Postmeiotic segregation increased 2 nirs variant 1 |
8.55 |
Evidence |
O
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
MRE11A |
MRE11A, HNGS1, MRE11: Double-strand break repair protein MRE11A |
8.402 |
Evidence |
|
| EXOSC2 |
EXOSC2, RRP4: Exosome complex exonuclease RRP4 |
EXOSC7 |
EXOSC7, KIAA0116, RRP42: Exosome complex exonuclease RRP42 |
8.345 |
Evidence |
O
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CD2AP |
CD2AP: CD2-associated protein |
8.19 |
Evidence |
O
|
| HCK |
IPI00029769 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
7.855 |
Evidence |
|
| PEX19 |
PEX19, HK33, OK/SW-cl.22, PXF: Peroxisomal biogenesis factor 19 |
ABCD2 |
ABCD2, ALD1, ALDL1, ALDR, ALDRP: ATP-binding cassette sub-family D member 2 |
7.54 |
Evidence |
|
| HRBL |
HRBL, RABR: HIV-1 Rev-binding protein-like protein |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
7.205 |
Evidence |
|
